BAY-U-3405 INHIBITS CEREBRAL VASOSPASM INDUCED BY AUTHENTIC THROMBOXANE-A2

被引:0
|
作者
BRAUN, M
SCHROR, K
机构
关键词
CEREBRAL VASOSPASM; THROMBOXANE-A2;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Platelet activation results in the formation of various vasoactive mediators such as thromboxane A2 and serotonin. We investigated the effects of Bay U 3405 [(3R)-3-(4-fluorophenyl-sulfonamido)-1,2,3,4,-tetrahydro-9-carbazolepropanoic acid] on vasocontractions of isolated bovine cerebral arteries induced by U 46.619, a stable thromboxane/prostaglandin-endoperoxide analogue, and authentic thromboxane A2 released from thrombin-stimulated human platelets. Bay U 3405 (0.001-10 mu-mol/1) potently inhibited the contraction induced by U 46.619 and demonstrated a reduction of the thromboxane-mediated component of platelet-induced contractile response at higher concentrations (0.1-10 mu-mol).
引用
收藏
页码:152 / 154
页数:3
相关论文
共 50 条
  • [31] Effects of thromboxane A(2) receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs
    Narita, S
    Asakura, K
    Kataura, A
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 109 (02) : 161 - 166
  • [32] THE ACTION OF BAY U-3405, A SPECIFIC THROMBOXANE (TX) A2 ANTAGONIST, IN MODELS OF THROMBOEMBOLISM AND SUDDEN-DEATH
    PERZBORN, E
    SEUTER, F
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1178 - 1178
  • [33] THE THROMBOXANE RECEPTOR ANTAGONIST BAY U3405 REVERSES PROSTAGLANDIN-D2 (PGD2)-INDUCED BRONCHOCONSTRICTION IN THE ANESTHETIZED GUINEA-PIG
    FRANCIS, HP
    MORRIS, TG
    THOMPSON, AM
    PATEL, UP
    GARDINER, PJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 629 : 399 - 401
  • [34] HEART ATTACK INDUCED EXPERIMENTALLY WITH THROMBOXANE-A2
    SHIMAMOTO, T
    KOBAYASHI, M
    TAKAHASHI, T
    MOTOMIYA, T
    NUMANO, F
    MOROOKA, S
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 1977, 53 (01): : 38 - 42
  • [35] Further investigation of thromboxane-A2 induced arrhythmias
    Kosloski, LM
    Best, SR
    Wacker, MJ
    Porter, CB
    Orr, JA
    FASEB JOURNAL, 2006, 20 (04): : A320 - A321
  • [37] MATERNAL ASPIRIN INHIBITS FETAL PROSTACYCLIN AND THROMBOXANE-A2 IN HUMANS
    YLIKORKALA, O
    MAKILA, UM
    KAAPA, P
    VIINIKKA, L
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY, 1987, 6 (01): : 87 - 87
  • [38] BENEFICIAL-EFFECTS OF BAY U3405, A NOVEL THROMBOXANE A(2) RECEPTOR ANTAGONIST, IN SPLANCHNIC ARTERY-OCCLUSION SHOCK
    CANALE, P
    SQUADRITO, F
    ALTAVILLA, D
    IOCULANO, M
    CAMPO, GM
    SQUADRITO, G
    URNA, G
    SARDELLA, A
    CAPUTI, AP
    PHARMACOLOGY, 1994, 49 (06) : 376 - 385
  • [39] THROMBOXANE-A2 SYNTHESIS IN PREGNANCY-INDUCED HYPERTENSION
    FITZGERALD, DJ
    ROCKI, W
    MURRAY, R
    MAYO, G
    FITZGERALD, GA
    LANCET, 1990, 335 (8692): : 751 - 754
  • [40] ANTITHROMBOTIC ACTIVITY OF BAY-U3405, A THROMBOXANE A(2)-ANTAGONIST, INPATIENTS WITH DACRON AORTIC GRAFTS - A RANDOM CONTROLLED CLINICAL-TRIAL
    PIETERS, H
    ROODT, JP
    BADENHORST, PN
    VANWYK, V
    SCHALL, R
    LOTTER, MG
    HUNDT, HKL
    NEL, CJC
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (06) : 903 - 908